Active Penny Stocks in the News
PennyTrader.com presents a range of the hottest penny stocks on the OTC and OTCBB market today. In addition to daily hot stock alerts, PennyTrader.com‘s new penny stock alert service is fast becoming the premier stock alert list to be on.
Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/
Global Earth Energy, Inc. (OTCBB: GLER) reached up16.98% in morning trading to $.062 with 1M shares traded. Global Earth Energy, Inc. (OTC.BB:GLER - News) announced today that its wholly owned subsidiary RCI Solar, Inc., a North American provider of renewable energy products and services, has opened a new, 15,000 square foot, state-of-the-art facility that doubles its current capacity to serve customers throughout Ontario, Canada. The new facility houses all of the warehousing, distribution, inventory management and fulfillment functions.
For detailed quote and full article http://www.pennytrader.com/quotes/GLER.php
Biocentric Energy Holdings, Inc. (Pink Sheets: BEHL) was up 16% in morning trading to $.0029 with 21M shares traded. BioCentric Energy Holdings Inc., through its subsidiaries, engages in the discovery and development of renewable energy projects in the United States and internationally. It manufactures and sells closed loop algae bioreactor systems for commercialization and production of algae. Biocentric Energy Holdings, Inc. (Pink Sheets:BEHL - News) Dennis Fisher, Founder and Chairman of the Board today announced contracts for algae derived products are in the process of finalization.
For detailed quote and full article http://www.pennytrader.com/quotes/BEHL.php
Geron Corporation (Nasdaq: GERN) was up 12.08% in morning trading to $5.38 with 1M shares traded Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials in different cancers. Geron Corporation (Nasdaq:GERN - News) announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron’s Investigational New Drug (IND) application has been lifted and the company’s Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
For detailed quote and full article http://www.pennytrader.com/quotes/GERN.php
Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks
in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report
For complete disclosure information go to http://www.pennytrader.com/disclosure/
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to http://www.pennytrader.com/disclaimer/
